HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schneider, E. Articles by Dy, M. Search for Related Content PubMed PubMed Citation Articles by Schneider, E. Articles by Dy, M.

Hematopoietic Changes Induced by a Single Injection of Anti-CD3 Monoclonal Antibody into Normal Mice

Université René Descartes - Paris V, CNRS URA 1461, Hôpital Necker, Paris, France

Key Words. CFU-C • IL-3 • GM-CSF • Histamine

Dr. Elke Schneider, CNRS URA 1461, Hôpital Necker, 161 rue de Sèvres, 75743 Paris Cedex 15, France.

The present study evaluates hematopoietic modifications consecutive to in vivo treatment of mice with anti-CD3 monoclonal antibodies (mAb). The hamster mAb 145-2C11, administered in a single i.v. injection of 10 µg, induced the release of both interleukin 3 (IL-3) and GM-CSF into the circulation. IL-3 could be detected in the serum within 1 h, attained maximal levels after 4 h and had disappeared after 24 h. Three days later, treated mice exhibited a two- to threefold rise in blood neutrophil levels and increased spleen cell counts. Concomitantly, the incidence of nucleated erythroid cells in these spleens increased around 10-fold, relative to controls having received hamster Ig. At the same time point, clonogenic progenitor frequencies were 10-fold higher in spleens from treated mice than in those from control mice. Furthermore, the responsiveness of these splenocytes to IL-3, in terms of histamine synthesis, was enhanced. In contrast, bone marrow cell populations were only slightly affected by anti-CD3 injection. All hematopoietic changes required multivalent crosslinking of the mAb for induction, since F(ab')₂ fragments lacked this activity. A return to normal occurred 7-10 days after treatment. Two i.v. injections of recombinant murine IL-3 together with recombinant murine GM-CSF on a single day had a less pronounced effect on progenitor cell frequencies in the spleen than treatment with anti-CD3. This difference is probably due to the amplification of growth factor-induced hematopoiesis by the interaction with other cytokines generated in response to anti-CD3.

This article has been cited by other articles:

				J. P. Monteiro, A. Benjamin, E. S. Costa, M. A. Barcinski, and A. Bonomo Normal hematopoiesis is maintained by activated bone marrow CD4+ T cells Blood, February 15, 2005; 105(4): 1484 - 1491. [Abstract] [Full Text] [PDF]